维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="AITHAL GP"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications显示文摘	Aithal GP Day CP Kesteven PJ		0，，：	1
2	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarindose requirement and risk of bleeding complications显示文摘	Aithal GP Day CP Kesteven PJ	1999	Lancet1999，353，9154：	1
3	Randomized, placebo -controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis显示文摘	Aithal GP Thomas JA Kaye PV	2008	Gastroenterology2008，135，4：	1
4	Guidelines on the management of ascites in cirrhosis 显示文摘	Moore KP Aithal GP	2006	Gut2006，55，6：	1
5	Guidelines on the management of asci- tes in cirrhosis显示文摘	Moore KP Aithal GP	2006	Gut2006，55，6：	1
6	Guidelines on the management of ascites in cirrhosis显示文摘	Moore KP Aithal GP		0，，6：	1
7	Genetic susceptibility to diclofenac - induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes 显示文摘	Daly AK Aithal GP Leathart JB	2007	Gastroenterology2007，132，：	1
8	Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis:are serial liver biopsies justified?显示文摘	Aithal GP Haugk B Das S	2004	Aliment Pharmacol Ther2004，19，：	1
9	Case definition andphenotype standardization in drug-induced liver injury 显示文摘	Aithal GP Watkins PB Andrade RJ	2011	ClinPharmacol Ther2011，89，6：	1
10	Case definition and phenotype standardization in drug-induced liver injury显示文摘	Aithal GP Watkins PB Andrade RJ	2011	Clin Pharmacol Ther2011，89，6：	1
11	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications 显示文摘	Aithal GP Day CP Kesteven PJ	1999	Lancet1999，353，9154：	1
12	Association of single nucleotide polymorphisms in the interlukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population显示文摘	Aithal GP Day CP Leathert J Daly AK Hudson M	2001	Genes Immun2001，2，1：	1
13	Guidelines on the management of ascites in cir- rhosis 显示文摘	Moone KP Aithal GP	2006	Gut2006，55，6：	1
14	Case definition and phenotype standardization in drug-induced liver injury显示文摘	Aithal GP Watkins PB Andrade RJ	2011	Clin Pharmacol Ther2011，89，6：	1
15	Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatoxic adverse drug reactions 显示文摘	Aithal GP Rawlins MD Day GP	2000	J Hepatol2000，33，6：	1
16	Association of polymorphisms in the cytochrome P450 CYP2C9 with dose requirement and risk of bleeding complications显示文摘	Aithal GP Day CP Kesteven PJL Daly AK	1999	Lancet1999，353，：	1
17	Case definition and phenotype standardization in drug-induoed liver injury 显示文摘	Aithal GP Watkins PB Andrade R J	2011	Clin Pharmacol Ther2011，89，：	1
18	Genetic susceptibility to di- elofenae-indueed hepatotoxieity : contribution of UGT2B7, CYP2C8, and ABCC2 genotypes显示文摘	Daly AK Aithal GP Leathart JB	2007	Gastroenterology2007，132，：	1
19	Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions 显示文摘	Aithal GP Rawlins MD Day CP	2000	J Hepatol2000，33，6：	1
20	Association of polymorphism in the cytochrome P450 CYP2C9 with warfarin dose requirements and risk of bleeding complications显示文摘	Aithal GP Day CP Kesteven PJ	1999	Lancet1999，353，9154：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示